Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL
Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL
Recruiting · NCT07271121 · Registry updated 2025-12-09Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of CART Cell (MB-CART19.1) in Patients With Relapsed or Refractory CD19 Positive NHL | Non-Hodgkin Lymphoma Refractory/ Relapsed | Recruiting | Phase 2 | 2025-12-09 | NCT07271121 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| King Hussein Cancer Center | 9 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| King Hussein Cancer Center | Amman | Jordan | 7 |